Role of interleukin-6 in cachexia: therapeutic implications

Area of Science:

• Oncology
• Immunology
• Metabolism

Background:

• Interleukin-6 (IL-6) is a cytokine implicated in cancer cachexia.
• Cachexia affects adipose, skeletal muscle, gut, and liver tissues, impacting patient recovery.

Purpose of the Study:

• To review recent breakthroughs in targeting IL-6 for cancer cachexia therapy.
• To explore findings from animal models and human studies.

Main Methods:

• Review of existing literature on IL-6 and cancer cachexia.
• Analysis of data from animal models and clinical trials.

Main Results:

• IL-6 signaling, particularly via IL-6 trans-signaling, exacerbates cachexia by inducing protein degradation in skeletal muscle.
• Blocking IL-6 pathways in mouse models attenuated cachexia progression.
• Pharmaceuticals targeting IL-6 relieved cachectic symptoms in cancer patients.
• Exercise and nutraceuticals may modulate IL-6 signaling in cachexia.

Conclusions:

• IL-6 is a promising therapeutic target for cancer cachexia across various cancer types.
• A deeper understanding of IL-6's direct, indirect, and tissue-specific effects is needed for treatment optimization.